Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prolife IndustriesNSE:PROLIFE 73 Equity-to-Asset is 0.91 as of Mar. 2026, which is 94% above its 10-year median of 0.47. GuruFocus rates NSE:PROLIFE with a GF Score™ of 73/100 and a GF Value™ of ₹168.52 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,622 Chemicals companies, Prolife Industries ranks better than 95.87% on this metric.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Prolife Industries Equity-to-Asset Related Terms
Prolife Industries Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Prolife Industries's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Prolife Industries's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prolife Industries Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Prolife Industries's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Prolife Industries's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Prolife Industries's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prolife Industries (NSE:PROLIFE) has a Equity-to-Asset of 0.91 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Prolife Industries and its competitors. This is 94% above median its historical median of 0.47. Over the past decade, Prolife Industries' Equity-to-Asset has ranged from 0.44 to 0.91. According to the industry distribution chart, Prolife Industries ranks #67 out of 1622 companies in the Chemicals industry, placing it in the top 4.1%.
Is Prolife Industries' Equity-to-Asset too high?
Prolife Industries' current Equity-to-Asset of 0.91 is 94% above median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 0.91. The Chemicals industry median Equity-to-Asset is 0.60. Prolife Industries' value of 0.91 is 51.7% above this industry median. Based on the distribution chart, Prolife Industries ranks #67 out of 1622 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Prolife Industries has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prolife Industries' Equity-to-Asset compare to DOW?
According to the Chemicals industry distribution chart, Prolife Industries ranks #67 out of 1622 companies for Equity-to-Asset. This places Prolife Industries in the top 4% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.60. Prolife Industries' value of 0.91 is 51.7% above this benchmark. Historically, Prolife Industries' own Equity-to-Asset has ranged from 0.44 to 0.91 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 0.60, Prolife Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,622 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prolife Industries's current Equity-to-Asset of 0.91 is 51.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Prolife Industries and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prolife Industries's current Equity-to-Asset is 0.91, which is 94% above median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolife Industries stock overvalued right now?
Based on GuruFocus' analysis, Prolife Industries (NSE:PROLIFE) is currently considered Possible Value Trap. The stock's GF Value™ is ₹168.52, compared to a current price of ₹79.00 — trading 53.1% below its estimated fair value. The current Equity-to-Asset is 0.91, which is 94% above median its 10-year median of 0.47 and 51.7% above the Chemicals industry median of 0.60. Prolife Industries' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Prolife Industries (NSE:PROLIFE), the current Equity-to-Asset is 0.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prolife Industries (NSE:PROLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Prolife Industries stock appears to be undervalued.
The current stock price of ₹79.00 is trading 53.1% below its estimated GF Value™ of ₹168.52.
GuruFocus considers Prolife Industries to be Possible Value Trap.
Key valuation signals for NSE:PROLIFE:
Equity-to-Asset: 0.91 (94% above median its 10-year median of 0.47)
GF Value™: ₹168.52 vs. price of ₹79.00 (53.1% below fair value)
Industry Position: 51.7% above the Chemicals median (#67 of 1622)
No single metric tells the full story. See the NSE:PROLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prolife Industries Ltd is engaged in the business of manufacturing of intermediates for dyes, pigments, pharmaceuticals, agrochemicals, and others. Its products include Dihydro Thio Para Toluidine Sulfonic Acid, Amino Methyl Phenoxy Sulfonic Acid, and others. The company derives revenue from both domestic and overseas markets, which are considered different geographical segments.
73GF Score
Get the complete analysis for NSE:PROLIFE
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PROLIFE has been successfully added to your 
